For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Congratulations on your engagement…
Wednesday 15 December 2021, 12:03 AM

General practice has often been shut out of COVID-19 response planning, leaving patients in a precarious position [Tim Mossholder on Unsplash]
GENPRO
Tim Malloy says model-of-care codesign with general practice might have made a momentous difference for self-isolating COVID-19 patients
Policy announcements are treated like State secrets until they are used as media opportunities
Somebody who was probably older and undoubtedly wi
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.